-
公开(公告)号:US20110144068A1
公开(公告)日:2011-06-16
申请号:US13054853
申请日:2009-07-23
申请人: Maurizio Pulici , Fabio Zuccotto , Alessandra Badari , Stefano Nuvoloni , Giovanni Cervi , Gabriella Traquandi , Sonia Biondaro , Paolo Trifiro' , Chiara Marchionni , Michele Modugno
发明人: Maurizio Pulici , Fabio Zuccotto , Alessandra Badari , Stefano Nuvoloni , Giovanni Cervi , Gabriella Traquandi , Sonia Biondaro , Paolo Trifiro' , Chiara Marchionni , Michele Modugno
IPC分类号: A61K31/635 , C07D401/04 , C07D413/14 , C07D405/14 , C07D401/14 , C07D513/04 , C07D409/14 , C07D417/14 , C07D403/04 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/506 , C12N5/09 , A61P35/00 , A61P35/02 , A61P17/06 , A61P19/02 , A61P35/04
CPC分类号: C07D401/04 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/506 , A61K31/635 , A61K45/06 , C07D401/14 , C07D403/04 , C07D405/14 , C07D407/14 , C07D409/14 , C07D413/14 , C07D513/14
摘要: 3,4-diarylpyrazole derivatives of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
摘要翻译: 公开了说明书中定义的式(I)的3,4-二芳基吡唑衍生物及其药学上可接受的盐,其制备方法和包含它们的药物组合物; 本发明的化合物在治疗中可用于治疗与失调的蛋白激酶活性相关的疾病,如癌症。
-
公开(公告)号:US08946250B2
公开(公告)日:2015-02-03
申请号:US13970854
申请日:2013-08-20
申请人: Maurizio Pulici , Fabio Zuccotto , Gabriella Traquandi , Sonia Biondaro , Paolo Trifiro′ , Alessandra Badari , Stefano Nuvoloni , Giovanni Cervi , Chiara Marchionni , Michele Modugno
发明人: Maurizio Pulici , Fabio Zuccotto , Gabriella Traquandi , Sonia Biondaro , Paolo Trifiro′ , Alessandra Badari , Stefano Nuvoloni , Giovanni Cervi , Chiara Marchionni , Michele Modugno
IPC分类号: A01N43/54 , A61K31/505 , A01N43/40 , A61K31/44 , C07D239/02 , C07D401/00 , C07D401/04 , C07D403/04 , C07D407/14 , C07D409/14 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/506 , A61K31/635 , A61K45/06 , C07D401/14 , C07D405/14 , C07D413/14 , C07D513/14
CPC分类号: C07D401/04 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/506 , A61K31/635 , A61K45/06 , C07D401/14 , C07D403/04 , C07D405/14 , C07D407/14 , C07D409/14 , C07D413/14 , C07D513/14
摘要: 3,4-diarylpyrazole derivatives of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
摘要翻译: 公开了说明书中定义的式(I)的3,4-二芳基吡唑衍生物及其药学上可接受的盐,其制备方法和包含它们的药物组合物; 本发明的化合物在治疗中可用于治疗与失调的蛋白激酶活性相关的疾病,如癌症。
-
公开(公告)号:US20140005150A1
公开(公告)日:2014-01-02
申请号:US13970854
申请日:2013-08-20
申请人: Maurizio Pulici , Fabio Zuccotto , Gabriella Traquandi , Sonia Biondaro , Paolo Trifiro' , Alessandra Badari , Stefano Nuvoloni , Giovanni Cervi , Chiara Marchionni , Michele Modugno
发明人: Maurizio Pulici , Fabio Zuccotto , Gabriella Traquandi , Sonia Biondaro , Paolo Trifiro' , Alessandra Badari , Stefano Nuvoloni , Giovanni Cervi , Chiara Marchionni , Michele Modugno
IPC分类号: C07D401/04 , A61K45/06 , C07D405/14 , C07D413/14 , A61K31/635 , C07D409/14 , C07D401/14 , A61K31/444 , A61K31/4545 , C07D403/04 , A61K31/506 , A61K31/4439 , C07D513/14
CPC分类号: C07D401/04 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/506 , A61K31/635 , A61K45/06 , C07D401/14 , C07D403/04 , C07D405/14 , C07D407/14 , C07D409/14 , C07D413/14 , C07D513/14
摘要: 3,4-diarylpyrazole derivatives of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
摘要翻译: 公开了说明书中定义的式(I)的3,4-二芳基吡唑衍生物及其药学上可接受的盐,其制备方法和包含它们的药物组合物; 本发明的化合物在治疗中可用于治疗与失调的蛋白激酶活性相关的疾病,如癌症。
-
公开(公告)号:US08541575B2
公开(公告)日:2013-09-24
申请号:US13054853
申请日:2009-07-23
申请人: Maurizio Pulici , Fabio Zuccotto , Alessandra Badari , Stefano Nuvoloni , Giovanni Cervi , Gabriella Traquandi , Sonia Biondaro , Paolo Trifiro' , Chiara Marchionni , Michele Modugno
发明人: Maurizio Pulici , Fabio Zuccotto , Alessandra Badari , Stefano Nuvoloni , Giovanni Cervi , Gabriella Traquandi , Sonia Biondaro , Paolo Trifiro' , Chiara Marchionni , Michele Modugno
IPC分类号: C07D239/02 , C07D213/04 , A01N43/54
CPC分类号: C07D401/04 , A61K31/4439 , A61K31/444 , A61K31/4545 , A61K31/506 , A61K31/635 , A61K45/06 , C07D401/14 , C07D403/04 , C07D405/14 , C07D407/14 , C07D409/14 , C07D413/14 , C07D513/14
摘要: 3,4-diarylpyrazole derivatives of formula (I) as defined in the specification, and pharmaceutically acceptable salts thereof, process for their preparation and pharmaceutical compositions comprising them are disclosed; the compounds of the invention may be useful, in therapy, in the treatment of diseases associated with a disregulated protein kinase activity, like cancer.
-
-
-